Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Bioarctic Says Co & Eisai Announced Today That Leqembi Has Been Approved For Treatment Of Alzheimer's Disease In Israel

July 11 (Reuters) - BioArctic AB  BIOAb.ST :
    * BIOARCTIC AB - CO & EISAI ANNOUNCED TODAY THAT LEQEMBI HAS
BEEN
APPROVED FOR TREATMENT OF ALZHEIMER'S DISEASE IN ISRAEL

Source text for Eikon:  ID:nWkr8hYbDb 
Further company coverage:  BIOAb.ST 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on BioArctic AB

See all news